Annual Revenue ($)

International Stem Cell Corporation revenue was $7.13 m in FY, 2020

Quarterly Revenue ($)

FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020
Revenue$4.53 m$4.57 m$6.15 m$7.02 m$7.55 b$7.17 m$7.46 m$11.09 m$9.47 m$7.13 m
Q2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q1, 2021
Revenue$1.11 m$842.06 k$1.08 m$1.06 m$1.19 m$1.29 m$1.46 m$1.67 m$1.65 m$1.59 m$1.96 m$1.62 m$1.82 b$2.14 b$1.62 b$1.92 b$1.94 b$2.01 b$1.76 m$1.85 b$2.63 m$5.67 m$3.2 m$2.22 m$2.32 m$2.1 m$2.36 m$1.81 m$1.66 m

Annual Growth Rate (%)

Revenue Breakdown

Business Segment

Geographic Segment

International Stem Cell Corporation revenue breakdown by business segment: 30.3% from Cosmetic and 69.7% from Biomedical

International Stem Cell Corporation revenue breakdown by geographic segment: 85.1% from North America, 9.8% from Asia and 5.1% from Other

FY, 2017FY, 2016
Cosmetic$2.26 m$2.85 m
Biomedical$5.2 m$4.32 m
FY, 2017FY, 2016
North America$6.35 m$6.06 m
Europe$354 k$362 k
Other$27 k$40 k
Asia$728 k$702 k

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Footer menu